Search | Clinical Trials Finder

Independent directory Public ClinicalTrials.gov records United States

ClinicalTrials.gov public records Last synced Sep 24, 2026, 5:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 81 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Intervention: Teriparatide (FORTEO) Clear all

Conditions: Postmenopausal Osteoporosis
Interventions: Teriparatide, Denosumab; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 45 Years and older · Female only
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Osteoporosis
Interventions: zoledronic acid; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: Up to 85 Years · Female only
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Osteoporosis
Interventions: Teriparatide; Drug
Lead sponsor: Pfenex, Inc; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Evansville, Indiana

Conditions: Osteoporosis, Bone Loss, Spinal Cord Injury
Interventions: teriparatide, weight-bearing; Drug · Other
Lead sponsor: Thomas J. Schnitzer; Other
Eligibility: 18 Years to 75 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hypoparathyroidism Post-surgical
Interventions: Teriparatide; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 80 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Osteoporosis
Interventions: Zoledronic acid, Placebo, Teriparatide; Drug
Lead sponsor: Novartis; Industry
Eligibility: 45 Years to 89 Years · Female only
Enrollment: 412 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 18
States / cities: Birmingham, Alabama • Beverly Hills, California • La Mesa, California + 15 more

Conditions: Osteoporosis
Interventions: Teriparatide, Alendronate Sodium, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 21 Years and older
Enrollment: 428 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2008
U.S. locations: 6
States / cities: Loma Linda, California • Palo Alto, California • Aurora, Colorado + 3 more

Conditions: Osteoporosis
Interventions: Risedronate, Parathyroid Hormone; Drug
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Stress Fracture of Tibia or Fibula
Interventions: Teriparatide, Placebos; Drug
Lead sponsor: University of South Carolina; Other
Eligibility: Not listed
Enrollment: 183 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Osteoporosis
Interventions: Human parathyroid hormone [hPTH-(1-34)], alendronate; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 45 Years to 85 Years
Enrollment: 176 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2006
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Age-Related Osteoporosis
Interventions: Teriparatide, Alendronate; Drug
Lead sponsor: Madhumathi Rao; Other
Eligibility: 40 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Postmenopausal Osteoporosis
Interventions: Romozosumab, Teriparatide; Drug
Lead sponsor: Amgen; Industry
Eligibility: 55 Years to 90 Years · Female only
Enrollment: 436 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 5
States / cities: Gainesville, Georgia • Bethesda, Maryland • Boston, Massachusetts + 1 more

Conditions: Fractures
Interventions: Teriparatide, Placebo; Drug
Lead sponsor: Ohio Orthopedic Center of Excellence; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Upper Arlington, Ohio

Conditions: Osteoporosis
Interventions: Risedronate, Teriparatide, Placebo Teriparatide, placebo Risedronate; Drug
Lead sponsor: Columbia University; Other
Eligibility: 30 Years to 85 Years · Male only
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteoporosis, Atypical Femoral Fracture
Interventions: teriparatide; Drug
Lead sponsor: Susan L. Greenspan; Other
Eligibility: Female only
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Kidney Failure, Chronic
Interventions: Alendronate, Teriparatide, Cinacalcet; Drug
Lead sponsor: Hartmut Malluche, MD; Other
Eligibility: 21 Years and older
Enrollment: 141 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Osteoporosis, Postmenopausal
Interventions: teriparatide, raloxifene HCl, placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 55 Years to 80 Years · Female only
Enrollment: 330 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2005
U.S. locations: 2
States / cities: Maywood, Illinois • Portland, Oregon

Conditions: Osteoporosis
Interventions: Teriparatide, Raloxifene; Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 60 Years to 89 Years · Female only
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Menopause, Fracture, Osteoporosis
Interventions: Teriparatide (PTH 1-34); Drug
Lead sponsor: Columbia University; Other
Eligibility: 20 Years to 48 Years · Female only
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 2
States / cities: Omaha, Nebraska • New York, New York

Conditions: Postmenopausal Osteoporosis, Osteoporosis
Interventions: synthetic hPTH 1-34; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 46 Years to 85 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Osteoporosis, Postmenopausal Osteoporosis
Interventions: Placebo, BA058 80 mcg, teriparatide; Drug
Lead sponsor: Radius Health, Inc.; Industry
Eligibility: 50 Years to 85 Years · Female only
Enrollment: 2,463 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 5
States / cities: Lakewood, Colorado • Miami, Florida • North Miami, Florida + 2 more

Conditions: Osteoporosis, Postmenopausal
Interventions: teriparatide, raloxifene, placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 45 Years to 85 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 13
States / cities: Anaheim, California • Oakland, California • Altamonte Springs, Florida + 10 more

Conditions: Osteoporosis
Interventions: Ronacaleret, Teriparatide, Alendronate; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 79 Years · Female only
Enrollment: 564 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 9
States / cities: Oakland, California • Palm Desert, California • Walnut Creek, California + 6 more

Conditions: Osteoporosis, Postmenopausal
Interventions: teriparatide, Placebo, Calcium Supplement, Vitamin D Supplement; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 30 Years to 85 Years · Female only
Enrollment: 1,637 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 1999
U.S. locations: 1
States / cities: Boston, Massachusetts